About Bioceptive
Bioceptive is a company based in New Orleans (United States) founded in 2010. It operates as a Direct-to-Consumer (D2C). Bioceptive has raised $2.94 million across 6 funding rounds from investors including New World Angels. The company has 2 employees as of December 31, 2022. Bioceptive offers products and services including Cervical Suction Retractor and IUD Inserter. Bioceptive operates in a competitive market with competitors including FEMSelect, Pharmiva, AVeta Medical, Madorra and Aqueduct Medical, among others.
- Headquarter New Orleans, United States
- Employees 2 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioceptive Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.94 M (USD)
in 6 rounds
-
Latest Funding Round
$416.45 K (USD), Seed
Jan 29, 2016
- Investors
-
Employee Count
2
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioceptive
Bioceptive offers a comprehensive portfolio of products and services, including Cervical Suction Retractor and IUD Inserter.
Device used to replace tenaculum in GYN procedures.
Tool designed to improve IUD insertion accessibility.
People of Bioceptive
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Bioceptive
Bioceptive has successfully raised a total of $2.94M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $416.45 thousand completed in January 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bioceptive
Bioceptive has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include New World Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage funding and guidance are provided to Florida entrepreneurs.
|
Locked | Locked | Locked |
Investor details for Bioceptive
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioceptive
Investment portfolio details for Bioceptive
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioceptive
Detailed financials for Bioceptive
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioceptive Comparisons
Peer comparison for Bioceptive
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioceptive
Bioceptive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as FEMSelect, Pharmiva, AVeta Medical, Madorra and Aqueduct Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A minimally invasive surgical system for uterine prolapse is developed.
|
|
| Locked | Locked | Locked |
Developer of smart medical devices against bacterial vaginosis in women
|
|
| Locked | Locked | Locked |
Non-hormonal device for menopause symptoms is developed using wound-healing process.
|
|
| Locked | Locked | Locked |
Therapeutic device for vaginal atrophy and dryness treatment is provided.
|
|
| Locked | Locked | Locked |
Develops cervical dilator devices for intrauterine procedures.
|
Detailed competitors of Bioceptive
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioceptive
Complete news archive for Bioceptive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioceptive
Bioceptive was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Bioceptive is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
Bioceptive is a funded company, having raised a total of $2.94M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Bioceptive is 2.
Bioceptive is engaged in the development of advanced medical devices for womens health. Based in New Orleans, the company is dedicated to creating solutions that reduce pain, improve access, and enhance outcomes in gynecological procedures. Their products, such as the Cervical Suction Retractor and IUD Inserter, are designed to address unmet needs in the healthcare sector. Emphasis is placed on improving patient comfort and procedural efficiency for healthcare professionals. Partnerships and joint ventures, like the one with Trimedic, are pursued to expand market reach in the United States and Canada.
Bioceptive's top competitors include FEMSelect, Madorra and AVeta Medical.
Bioceptive offers Cervical Suction Retractor and IUD Inserter.
Bioceptive has 1 investor. Key investors include New World Angels.